Sars-Cov-2 Vaccination Coverage in a Mexican Population with Rheumatic Disease
Journal of Clinical Rheumatology
; 29(4 Supplement 1):S68, 2023.
Article
in English
| EMBASE | ID: covidwho-2326680
ABSTRACT
Objectives:
Latest recommendation on SARS-CoV-2 vaccination in patients with systemic rheumatic diseases (SRD) by the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) is 3 doses while the Centers for Diseases Control and Prevention (CDC) recommends 5 doses. Method(s) We performed a cross-sectional study from April to November 2022 about SARS-CoV-2 vaccination in an outpatient rheumatology clinic in northeast Mexico. Consecutive SRD patients with a history of COVID-19 vaccination were invited to participate. Patients without SRD were excluded. Eligible participants completed a survey that included demographic data (age, sex, rheumatic disease diagnosis) and SARS-CoV-2 vaccination history (number of doses, and type of vaccine). Result(s) We recruited 252 patients.Vaccine types administered were BNT162b2 (Pfizer-BioNTech) 55 (23.11%);ChAdOx1 nCoV-19/AZD1222 (Oxford-AstraZeneca) 130 (54.62%);Ad5-nCoV (CanSinoBIO) 31 (13.03%);Coronavac (Sinovac) 9 (3.78%);mRNA-1273 (Moderna)13 (5.46%). (See Table 1 and Table 2) Conclusion(s) Two thirds of our patients met SARS-CoV-2 vaccination recommendations by ACR and EULAR and 5.95% met CDC criteria. Population without any dose represents 6.74%. SARS-CoV-2 infection in vaccinated patients with SRD is associated with a better outcome compared with unvaccinated. Efforts to increase vaccination coverage need to be done.
covid-19; Systemic rheumatic diseases; Vaccines; adult; conference abstract; controlled study; coronavirus disease 2019; cross-sectional study; demographics; disease control; drug therapy; female; human; major clinical study; male; Mexican; Mexico; nonhuman; outcome assessment; outpatient; rheumatic disease; rheumatology; Severe acute respiratory syndrome coronavirus 2; vaccination; vaccination coverage; vaccinee; ad5 ncov; coronavac; elasomeran; tozinameran; vaxzevria
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Observational study
/
Prognostic study
/
Randomized controlled trials
Topics:
Vaccines
Country/Region as subject:
Mexico
Language:
English
Journal:
Journal of Clinical Rheumatology
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS